Skip to search formSkip to main contentSkip to account menu

Asacol

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
  • 2017
  • Corpus ID: 62785572
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ASACOL HD safely and… 
2016
2016
Objective: To investigate the effects of hydroalcoholic extract of Ziziphus jujuba on the histopathological, tissue oxidative… 
2015
2015
Background: Oral 5-aminosalicylic acid (5-ASA) therapy is the first choice therapy for ulcerative colitis (UC), and adherence to… 
2012
2012
♦ Mezavant 1.2g is a higher-strength, delayed and extended-release tablet formulation of mesalamine, a drug also known as 5… 
2009
2009
DESCRIPTION: Each Asacol delayed-release tablet for oral administration contains 400 mg of mesalamine, an anti-inflammatory drug… 
1997
1997
IN RESPONSE: Drs. Mogadam, Ando, and Guslandi and Tittobello raise many interesting points. Dr. Mogadam states that a 30… 
1992
1992
Asacol (mesalamine) is a delayed release pH-sensitive, polymer-coated, oral preparation of 5-ASA which releases the drug in the…